Yu-ping Chang

7 Chung Shan South Road
TPQ 10002, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Complex interplay of metabolic dysfunction, hepatic and systemic inflammation, and ferritin dynamics following hepatitis C virus treatment: Further exploration of these links is needed.

Complex interplay of metabolic dysfunction, hepatic and systemic inflammation, and ferritin dynamics following hepatitis C virus treatment: Further exploration of these links is needed.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 17, 2026

Ferritin trajectories after hepatitis C virus treatment: Methodological insights.

Ferritin trajectories after hepatitis C virus treatment: Methodological insights.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 11, 2026

Ferritin dynamics following antiviral treatment in patients with hepatitis C virus infection: Impact of time-dependent metabolic factors.

Ferritin dynamics following antiviral treatment in patients with hepatitis C virus infection: Impact of time-dependent metabolic factors.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 08, 2026

Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.

Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.

Journal: Gut

Published: February 17, 2026

Response to "The unresolved link between MASLD and long-term ferritin dynamics in HCV-cured patients".

Response to "The unresolved link between MASLD and long-term ferritin dynamics in HCV-cured patients".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: December 13, 2025

Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies.

Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies.

Journal: Cancers

Published: November 27, 2025

Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: Gut

Published: October 14, 2025

Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.

Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.

Journal: Scientific reports

Published: September 14, 2025

Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Journal of gastroenterology and hepatology

Published: September 03, 2025

Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis.

Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis.

Journal: Journal of medical virology

Published: August 31, 2025

Letter: Post-HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations-A Critical Research Need. Authors' Reply.

Letter: Post-HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations-A Critical Research Need. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 16, 2025

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection-Authors' Reply.

Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: February 23, 2025

Showing 1-12 of 29

Last Updated: 09/26/2026